MORBIDLY ADHERENT PLACENTA IN PATIENTS WITH PLACENTA PREVIA AND FETO-MATERNAL OUTCOMES

Main Article Content

Humaira Tahir
Shahnaz Iqbal
Kausar Parveen
Shah Bibi
Aneela Gul Shaikh
Sakina Ali

Keywords

placenta previa, morbidly adherent placenta, feto-maternal outcomes

Abstract

Background: Morbidly Adherent Placenta (MAP) is characterized by the placenta's aberrant attachment to the uterus. It affects about 1 in 500 pregnancies and increases the risk of serious side effects, such as heavy bleeding after delivery, the need for a hysterectomy, and hospitalization in an intensive care unit. Those who have placenta previa, and especially those who have had a C-section delivery, are more at risk for developing MAP. Many Pakistani women with critical obstetric disorders go untreated because of a lack of knowledge and understanding of the importance of prenatal care. Many women either obtain their prenatal care at larger clinics or maternity homes, where the diagnosis is either made after the patient experiences significant bleeding or not at all, or they do not receive prenatal care at all.


Objective: To examine the prevalence of morbidly adherent placenta (MAP) and feto-maternal consequences in patients with placenta previa (PP).


Study design: A retrospective study


Place and Duration: This study was conducted in SESSI Landhi Hospital, Karachi Pakistan from November 2021 to November 2023.


Methodology: The study included information from postpartum women with placenta previa who had received an ultrasound diagnosis but varied in age, race, and ethnicity. The diagnosis of a morbidly adherent placenta was made after a thorough medical and physical evaluation of the patients, which included relevant tests like MRI and color Doppler ultrasonography. Medical indications were used to determine the most appropriate mode of cesarean delivery, which might be either an elective lower segment cesarean section (ElLSCS) or an emergency lower segment cesarean section (EmLSCS).


Result: A total of 50 patients were included in this research. The participants in this study had a mean gestational age of 34.79 weeks and an average age of 30.12 years. Out of all the cases, 48% had emergency C-sections, and 52% had elective ones. With type IV accounting for 54% of cases in this study, type III for 30% of the women, and type II for 16% of the cases, these were the most common types of placenta previa. In terms of maternal complications, antepartum hemorrhage (APH) occurred in 30% of patients, 40% of cases required cesarean hysterectomies, and no maternal deaths occurred. Fetal outcomes included low birth weight in 48% of babies and a 26% admission rate to the NICU.


Conclusion: In conclusion, placenta previa patients had a high frequency of morbidly adherent placenta, and this condition was clearly linked to poor feto-maternal outcomes.

Abstract 61 | Pdf Downloads 29

References

1. Rahman F, Khan Z, Ghani A, Gul A, Naveed Z, Sajjad W, Zaman SK. MORBIDLY ADHERENT PLACENTA IN PATIENTS WITH PLACENTA PREVIA AND FETO-MATERNAL OUTCOMES. Journal of Population Therapeutics and Clinical Pharmacology. 2023 Dec 22;30(19):1022-6.
2. Tahseen H, Khokhar S, Qurban S, Khurshid N, Tayyab M, Muneer N. Morbidly Adherent Placenta in Patients with Placenta Previa and feto-Maternal Outcomes. Journal of The Society of Obstetricians and Gynaecologists of Pakistan. 2023 Apr 26;13(2):69-72.
3. Radwan A, Abdou AM, Kafy S, Sheba M, Allam H, Bokhari M, Almutairi M. Maternal outcome of cases of placenta previa with and without morbidly adherent placenta at King Abdul-Aziz University Hospital, Saudi Arabia. Open Journal of Obstetrics and Gynecology. 2018 Oct 29;8(13):1414-22.
4. Afzal S, Akram R, Fatima T, Aslam M, Zafar A, Iqbal S. Fetomaternal Outcome with Placenta Previa and Morbidly Adherent Placenta, A Cross Sectional Study.
5. Raja RR, Rubini M. Maternal and perinatal outcome in placenta previa--one year study in tertiary care center in Tamil Nadu, India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2016 Aug 1;5(8):2819-23.
6. Ojha N. Obstetric factors and pregnancy outcome in placenta previa. Journal of Institute of Medicine Nepal (JIOMN). 2012 Aug 1;34(2).
7. Pradesh A. A Study on Fetomaternal Outcome in Cases of Placenta Previa in a Tertiary Health Care Hospital (King George Hospital, Andhra Medical College, Visakhapatnam, Andhra Pradesh).
8. Sorakayalapeta MR, Manoli NS. Maternal and perinatal outcome in placenta previa: an observational study at a tertiary care hospital in Mysore, Karnataka, India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2019 Apr 1;8(4):1322-7.
9. Gupta J, Hak J, Mehta L. Maternal and perinatal outcomes in pregnancy associated with placenta previa. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2022 Feb 1;11(2):522-7.
10. Ambreen A, Manzoor T, Intsar A, Khurshid S. One year review of maternal mortality and morbidity associated with placenta previa in a Tertiary Care Hospital. Annals of King Edward Medical University. 2012;18(2):201-.
11. Rac MW, Dashe JS, Wells CE, et al. Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol 2015; 212: 343.e1–7 .
12. Abdel-Hamid AS, Aly MS, Ghaly SZ, Elshourbagy MM. Detecting accuracy of three dimensional power Doppler (3DPD) vascular indices for prenatal diagnosis of morbidly adherent placenta in patients with placenta previa. Open Journal of Obstetrics and Gynecology. 2019 Dec 25;10(1):49-64.
13. Markley JC, Farber MK, Perlman NC, Carusi DA. Neuraxial anesthesia during cesarean delivery for placenta previa with suspected morbidly adherent placenta: a retrospective analysis. Anesthesia & Analgesia. 2018 Oct 1;127(4):930-8.
14. Haidar ZA, Papanna R, Sibai BM, Tatevian N, Viteri OA, Vowels PC, Blackwell SC, Moise Jr KJ. Can 3-dimensional power Doppler indices improve the prenatal diagnosis of a potentially morbidly adherent placenta in patients with placenta previa?. American Journal of Obstetrics and Gynecology. 2017 Aug 1;217(2):202-e1.
15. Alhubaishi F, Mahmood N. Prevalence and Fetomaternal Outcome of Placenta Previa at Salmaniya Medical Complex, Bahrain. Cureus. 2022 Aug 11;14(8).
16. Salim NA, Satti I. Risk factors of placenta previa with maternal and neonatal outcome at Dongola/Sudan. Journal of Family Medicine and Primary Care. 2021 Mar;10(3):1215
17. Maqsud M, Aiman Z, Ayub N, Tufail N, Waris N, Jabeen F. Placenta Previa and its Effects on Feto-Maternal Health at a Tertiary Care Hospital. J Soc Obstet Gynaecol Pak. 2020;10(1):30-34
18. Perveen S, Hasnain AZ. Scarred uterus; frequency of placenta praevia. Professional Med J Jun 2012;19(3): 000-000
19. Sultana R. Foeto-Maternal Outcome in Women with Placenta Praevia and Morbidly Adherent Placenta Praevia. Ann Pak Inst Med Sci. 2022; 18(3):212-217
20. Afzal S, Akram R, Fatima T, Aslam M, Zafar A, Iqbal S. Fetomaternal Outcome with Placenta Previa and Morbidly Adherent Placenta, A Cross Sectional Study.